Biodexa Pharmaceuticals Plc (BDRX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Biodexa Pharmaceuticals Plc (BDRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $544,662, listed on NASDAQ, employing roughly 11 people, carrying a beta of 1.19 to the broader market. Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Led by Stephen Anthony Stamp, public since 2015-12-07.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for BDRX as of 2026-09-22; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →